Metrion has invested in new laboratories, equipment, and staff, as part of the company's continued growth strategy to form strategic alliances and add "additional breadth."
ChanTest has received private equity financing by Ampersand
Ventures to enable the company to expand its library of ion
channel-expressing cell lines for drug screening.
Pharma firms can now follow US regulator's recommendations for
testing the cardiac safety of drug candidates more fully - thanks
to a new addition to Millipore's services.
Nanion has launched the world's smallest first generation of
throughput optimised patch-clamp automats. This drug discovery
technology is based on a micro-structured chip, which facilitates
electrophysiological experiments for...
A new high throughput ion channel screening service has been
launched by BioFocus, which will allow pharmaceutical companies to
pre-screen libraries against defined cell lines, identifying target
compounds and limiting the use of...
Quintiles Transnational has launched a new screening technology for
drug discovery and development to detect the interaction of
compounds with ion channels.